Evidence map›Paper›PMID 42653405›Full record

ArticleInternational journal of molecular sciences2026

The Proteome of Bone Marrow Multipotent Mesenchymal Stromal Cells Undergoes Significant Alterations in Acute Leukemia Patients at the Onset and During Treatment.

Nataliya A Petinati, Aleksandra V Sadovskaya, Irina N Shipounova, Nina I Drize, Anastasia N Vasilyeva, Olga A Aleshina, Alexandra S Paderina, Olga S Pokrovskaya, Larisa A Kuzmina, Igor P Smirnov and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nataliya A PetinatiNational Medical Research Center for Hematology, Moscow 125167, Russia.ORCID 0000-0001-6591-3183
Aleksandra V SadovskayaNational Medical Research Center for Hematology, Moscow 125167, Russia.ORCID 0000-0002-0221-9351
Irina N ShipounovaNational Medical Research Center for Hematology, Moscow 125167, Russia.ORCID 0000-0003-1189-0283
Nina I DrizeNational Medical Research Center for Hematology, Moscow 125167, Russia.ORCID 0000-0002-7150-0403
Anastasia N VasilyevaNational Medical Research Center for Hematology, Moscow 125167, Russia.
Olga A AleshinaNational Medical Research Center for Hematology, Moscow 125167, Russia.
Alexandra S PaderinaNational Medical Research Center for Hematology, Moscow 125167, Russia.
Olga S PokrovskayaNational Medical Research Center for Hematology, Moscow 125167, Russia.
Larisa A KuzminaNational Medical Research Center for Hematology, Moscow 125167, Russia.
Igor P SmirnovLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia.ORCID 0000-0003-0402-3392
Olga V PobegutsLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia.
Georgij P ArapidiLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia.ORCID 0000-0003-2323-1859
Maria A LagarkovaDepartment of Immunology, Faculty of Biology, Federal State Budget Educational Institution of Higher Education M.V., Lomonosov Moscow State University, Moscow 119991, Russia.ORCID 0000-0001-9594-1134
Elena N ParovichnikovaNational Medical Research Center for Hematology, Moscow 125167, Russia.

Funding

Russian Science Foundation 22-15-00018
6 · The paper itself

Abstract

The bone marrow stromal microenvironment is damaged in patients with acute leukemia. The aim of this study was to analyze changes associated with the extracellular matrix, mitochondrial function, and vesicular transport in the proteome of multipotent mesenchymal stromal cells (MSCs) in patients at the onset, in remission, before, and 1-3 months after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The study included paired MSCs samples from the bone marrow of 12 patients at the onset and in remission of acute leukemia (4 ALL, 8 AML) and eight patients before and after allo-HSCT (4 ALL, 4 AML). MSCs from eight healthy donors were used as a control. The growth characteristics and the proteome subsets describing extracellular matrix, mitochondria, and vesicular formation were studied. The proteome of the patients' MSCs differed significantly from that of the donor MSCs, both at the onset and in remission. Changes noted in the composition of extracellular matrix proteins may affect cell adhesion and access to growth factors. Significant changes were revealed in proteins affecting mitochondrial function. Vesicular transport proteins also differed between the donor and patient groups. Unexpectedly, no differences were found between the MSCs of donors and patients before and after allo-HSCT.

Indexed as

Bone Marrow CellsLeukemia, Myeloid, AcuteMesenchymal Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaProteomeAdolescentAdultExtracellular MatrixFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedMitochondriaYoung AdultProteomeacute leukemiaallo-HSCTbone marrow nicheECM remodelingmetabolismmitochondrial dysfunctionmultipotent mesenchymal stromal cellsproteome

Identifiers

PMID42653405
PMCPMC13513044

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.